Literature DB >> 14600786

Decreased serum level of antibody against human cytomegalovirus in patients with Behçet's disease.

Eun Bong Lee1, Ye Jin Kwon, Ki Chul Shin, Yeong Wook Song, Chung-Gyu Park, Eung-Soo Hwang, Chang-Yong Cha.   

Abstract

Behçet's disease (BD) is a connective tissue disorder characterized by recurrent orogenital ulcer, uveitis, and skin lesions. Recurrent aphthous ulcer is associated with human cytomegalovirus (HCMV). To investigate the possible role of HCMV in BD, we measured the titers of IgG, IgM, and IgA anti-HCMV antibodies in 73 Korean patients with BD, 50 with scleroderma, 70 with systemic lupus erythematosus, and 50 from healthy controls by indirect immunofluorescent staining. The titer of IgG anti-HCMV antibody was significantly lower in patients with BD than in controls (geometric mean 3115.4 vs 9687.6, P = 0.0001 by Wilcoxon's rank sum test), as was the titer of IgA anti-HCMV antibody (geometric mean 1.9 vs 15.7, P = 0.0001, Wilcoxon's rank sum test). In conclusion, we found significantly lower antibody responses to HCMV in patients with BD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600786     DOI: 10.1007/s00296-003-0394-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

Review 1.  Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.

Authors:  H Direskeneli
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

2.  Human cytomegalovirus infection and systemic lupus erythematosus.

Authors:  J R Rider; W E Ollier; R J Lock; S T Brookes; D H Pamphilon
Journal:  Clin Exp Rheumatol       Date:  1997 Jul-Aug       Impact factor: 4.473

Review 3.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

Review 4.  Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis.

Authors:  J P Pandey; E C LeRoy
Journal:  Arthritis Rheum       Date:  1998-01

5.  Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.

Authors:  N Sugi-Ikai; M Nakazawa; S Nakamura; S Ohno; M Minami
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-05       Impact factor: 4.799

6.  Close association of HLA-Bw51 with Behçet's disease.

Authors:  S Ohno; M Ohguchi; S Hirose; H Matsuda; A Wakisaka; M Aizawa
Journal:  Arch Ophthalmol       Date:  1982-09

7.  CD4 and CD8 cell responses to herpes simplex virus in Behçet's disease.

Authors:  C Young; T Lehner; C G Barnes
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

8.  Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12.

Authors:  M A Frassanito; R Dammacco; P Cafforio; F Dammacco
Journal:  Arthritis Rheum       Date:  1999-09

9.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

10.  Human cytomegalovirus as a potential etiologic agent in recurrent aphthous ulcers and Behçet's disease.

Authors:  A Sun; J G Chang; C L Kao; B Y Liu; J T Wang; C T Chu; J H Yuan; C P Chiang
Journal:  J Oral Pathol Med       Date:  1996-05       Impact factor: 4.253

View more
  2 in total

1.  Long-term safety outcome of systemic immunosuppression in pig-to-nonhuman primate corneal xenotransplantation.

Authors:  Se Hyun Choi; Chang Ho Yoon; Hyun Ju Lee; Hong Pyo Kim; Jong Min Kim; Jeong-Hwan Che; Kyoung Min Roh; Hyuk Jin Choi; Jiyeon Kim; Eung Soo Hwang; Chung-Gyu Park; Mee Kum Kim
Journal:  Xenotransplantation       Date:  2018-07       Impact factor: 3.907

2.  The seroprevalence and salivary shedding of herpesviruses in Behçet's syndrome and recurrent aphthous stomatitis.

Authors:  Noha Seoudi; Lesley A Bergmeier; Eleni Hagi-Pavli; David Bibby; Farida Fortune
Journal:  J Oral Microbiol       Date:  2015-06-05       Impact factor: 5.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.